Wuxi Biologics (Cayman) Inc. (WXIBF)
Market Closed
20 Jul, 20:00
OTC PINK 
$
4. 60
0
0%
$
17.77B Market Cap
- P/E Ratio
- Div Yield
1,557 Volume
- Eps
$ 4.6
Previous Close Want to track WXIBF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Wuxi Biologics (Cayman) Inc. (WXIBF) Statistics
Valuation metrics
Market Cap 17.77B
Enterprise value 126.14B
Trailing P/E (ttm) 26.82
Forward P/E -
PEG ratio 0.57
Price/Sales (ttm) 6.07
Price/Book (mrq) 2.85
Enterprise Value/Revenue 5.79
Enterprise Value/EBITDA 15.92
Overview
Shares outstanding 4.13B
Float 3.74B
Shares short -
% Held by insiders 0.1%
% Held by institutions 0.36%
Average volume (10 days) 553
Average volume (90 days) 6.22K
Price summary
52-Week low 3.63
52-Week high 5.61
Beta 0.58
50-Day moving average 4.34
200-Day moving average 4.5
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 3:1
Last split Date 10 Dec 2020
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.23%
Operating margin 0.3%
Operational effectiveness
Return on assets 0.08%
Return on equity 0.11%
Income Statement
Revenue (ttm) 3.21B
Revenue per share (ttm) 5.17
Quarterly revenue growth (yoy) 0.17%
Gross profit (ttm) 1.48B
EBITDA 8.49B
Net income to common (ttm) 722.85M
Diluted EPS (ttm) 1.16
Quarterly earnings growth (yoy) 0.38%
Balance Sheet
Total cash (mrq) 2.32B
Total cash per share (mrq) 3.73
Total debt (mrq) 457.14M
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 3.14%
Book value per share (mrq) 12.58
Cash Flow
Cash flow statement 933.83M
Levered free cash flow (LFCF) 630.92M
